ESPR insider transaction filings
Esperion Therapeutics, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-13. Screen ESPR transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-13 | 4 | Shepard Jay — Director | Disposition to issuer (D): 164,472 · Disposition to issuer (D): 21,000 (derivative) · Disposition to issuer (D): 32,500 (derivative) · Disposition to issuer (D): 44,000 (derivative) | EDGAR |
| 2026-07-13 | 4 | Fischer Seth H. Z. — Director | Disposition to issuer (D): 141,023 · Disposition to issuer (D): 21,000 (derivative) · Disposition to issuer (D): 32,500 (derivative) · Disposition to issuer (D): 44,000 (derivative) | EDGAR |
| 2026-07-13 | 4 | THOMPSON JOHN CRAIG — Director | Disposition to issuer (D): 79,873 · Disposition to issuer (D): 40,000 (derivative) | EDGAR |
| 2026-07-13 | 4 | Harlow John B. Jr. — Chief Commercial Officer | Disposition to issuer (D): 424,536 | EDGAR |
| 2026-07-13 | 4 | Looker Benjamin — Chief Legal Officer | Disposition to issuer (D): 667,524 · Disposition to issuer (D): 150,000 (derivative) · Disposition to issuer (D): 201,000 (derivative) · Disposition to issuer (D): 269,230 (derivative) | EDGAR |
| 2026-07-13 | 4 | Halladay Benjamin — Chief Financial Officer | Disposition to issuer (D): 705,410 · Disposition to issuer (D): 200,000 (derivative) · Disposition to issuer (D): 213,000 (derivative) · Disposition to issuer (D): 221,270 (derivative) | EDGAR |
| 2026-07-13 | 4 | Koenig Sheldon L. — President and CEO, Director | Disposition to issuer (D): 2,121,094 · Disposition to issuer (D): 642,000 (derivative) · Disposition to issuer (D): 753,000 (derivative) · Disposition to issuer (D): 647,460 (derivative) | EDGAR |
| 2026-07-13 | 4 | CARROLL J MARTIN — Director | Disposition to issuer (D): 177,523 · Disposition to issuer (D): 21,000 (derivative) · Disposition to issuer (D): 32,500 (derivative) · Disposition to issuer (D): 44,000 (derivative) | EDGAR |
| 2026-07-13 | 4 | Hoffman Robert E. — Director | Disposition to issuer (D): 85,153 · Disposition to issuer (D): 40,000 (derivative) · Disposition to issuer (D): 7,040 (derivative) | EDGAR |
| 2026-06-18 | 4 | Looker Benjamin — Chief Legal Officer | Sale (S): 11,824 @ $3.15 | EDGAR |
| 2026-06-18 | 4 | Koenig Sheldon L. — President and CEO, Director | Sale (S): 53,588 @ $3.15 | EDGAR |
| 2026-06-18 | 4 | Halladay Benjamin — Chief Financial Officer | Sale (S): 10,773 @ $3.15 | EDGAR |
| 2026-06-01 | 4 | THOMPSON JOHN CRAIG — Director | Grant/award (A): 79,873 @ $0 | EDGAR |
| 2026-06-01 | 4 | Shepard Jay — Director | Grant/award (A): 79,873 @ $0 | EDGAR |
| 2026-06-01 | 4 | Fischer Seth H. Z. — Director | Grant/award (A): 79,873 @ $0 | EDGAR |
| 2026-06-01 | 4 | CARROLL J MARTIN — Director | Grant/award (A): 79,873 @ $0 | EDGAR |
| 2026-06-01 | 4 | Hoffman Robert E. — Director | Grant/award (A): 79,873 @ $0 | EDGAR |
| 2026-03-18 | 4 | Looker Benjamin — Chief Legal Officer | Sale (S): 5,708 @ $2.70 | EDGAR |
| 2026-03-18 | 4 | Koenig Sheldon L. — President and CEO, Director | Sale (S): 25,578 @ $2.72 | EDGAR |
| 2026-03-18 | 4 | Halladay Benjamin — Chief Financial Officer | Sale (S): 6,424 @ $2.71 | EDGAR |
| 2026-03-16 | 4 | Looker Benjamin — Chief Legal Officer | Grant/award (A): 300,840 @ $0 · Grant/award (A): 269,230 (derivative) @ $0 | EDGAR |
| 2026-03-16 | 4 | Koenig Sheldon L. — President and CEO, Director | Grant/award (A): 723,760 @ $0 · Grant/award (A): 647,460 (derivative) @ $0 | EDGAR |
| 2026-03-16 | 4 | Halladay Benjamin — Chief Financial Officer | Grant/award (A): 247,430 @ $0 · Grant/award (A): 221,270 (derivative) @ $0 | EDGAR |
| 2026-01-21 | 4 | Looker Benjamin — General Counsel | Sale (S): 1,689 @ $2.88 | EDGAR |
| 2025-12-18 | 4 | Koenig Sheldon L. — President and CEO, Director | Sale (S): 48,244 @ $3.67 | EDGAR |
| 2025-12-18 | 4 | Halladay Benjamin — Chief Financial Officer | Sale (S): 7,337 @ $3.67 | EDGAR |
| 2025-12-18 | 4 | Looker Benjamin — General Counsel | Sale (S): 6,517 @ $3.67 | EDGAR |
| 2025-12-08 | 4 | Harlow John B. Jr. — Chief Commercial Officer | Grant/award (A): 424,536 @ $0 · Grant/award (A): 380,000 (derivative) @ $0 | EDGAR |
| 2025-10-20 | 4 | Looker Benjamin — General Counsel | Sale (S): 1,248 @ $2.62 | EDGAR |
| 2025-09-18 | 4 | Halladay Benjamin — Chief Financial Officer | Sale (S): 7,046 @ $2.81 | EDGAR |
| 2025-09-18 | 4 | Looker Benjamin — General Counsel | Sale (S): 6,267 @ $2.80 | EDGAR |
| 2025-09-18 | 4 | Koenig Sheldon L. — President and CEO, Director | Sale (S): 28,427 @ $2.79 | EDGAR |
| 2025-07-18 | 4 | Looker Benjamin — General Counsel | Sale (S): 1,304 @ $1.13 | EDGAR |
| 2025-07-18 | 4 | Halladay Benjamin — Chief Financial Officer | Sale (S): 11 @ $1.11 | EDGAR |
| 2025-07-02 | 4 | THOMPSON JOHN CRAIG — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-06-18 | 4 | Looker Benjamin — General Counsel | Sale (S): 6,422 @ $1.15 | EDGAR |
| 2025-06-18 | 4 | Koenig Sheldon L. — President and CEO, Director | Sale (S): 30,474 @ $1.11 | EDGAR |
| 2025-06-18 | 4 | Halladay Benjamin — Chief Financial Officer | Sale (S): 7,229 @ $1.15 | EDGAR |
| 2025-06-02 | 4 | Fischer Seth H. Z. — Director | Grant/award (A): 33,000 @ $0 · Grant/award (A): 44,000 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | Shepard Jay — Director | Grant/award (A): 33,000 @ $0 · Grant/award (A): 44,000 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | Woody Tracy M — Director | Grant/award (A): 88,000 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | CARROLL J MARTIN — Director | Grant/award (A): 33,000 @ $0 · Grant/award (A): 44,000 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | ROCAMBOLI STEPHEN — Director | Grant/award (A): 33,000 @ $0 · Grant/award (A): 44,000 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | VITULLO NICOLE — Director | Grant/award (A): 88,000 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | Hoffman Robert E. — Director | Grant/award (A): 5,280 @ $0 · Grant/award (A): 7,040 (derivative) @ $0 | EDGAR |
| 2025-04-21 | 4 | Warren Eric — Chief Commercial Officer | Sale (S): 108 @ $0.98 | EDGAR |
| 2025-04-21 | 4 | Halladay Benjamin — Chief Financial Officer | Sale (S): 8 @ $0.96 | EDGAR |
| 2025-04-02 | 4 | Hoffman Robert E. — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-03-19 | 4 | Halladay Benjamin — Chief Financial Officer | Sale (S): 3,535 @ $1.48 | EDGAR |
| 2025-03-19 | 4 | Warren Eric — Chief Commercial Officer | Sale (S): 2,433 @ $1.49 | EDGAR |
Recent 8-K events — Esperion Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-13 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-08 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-06-18 | 8-K/A | 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-16 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-06-09 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-06-01 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-01 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-02 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-03 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ESPR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →